Community evaluation of VECTRON™ T500 (broflanilide) for indoor residual spraying for malaria vector control in Siaya county, Kenya
VECTRON™ T500 demonstrated superior residual efficacy, excellent safety profile, and high community acceptance compared to Actellic™ 300CS. Its novel mode of action and absence of cross-resistance to pirimiphos-methyl and pyrethroids make it valuable for insecticide resistance management in malaria vector control programmes.
Authors
- Seline Omondi
- Mathew Kipsum
- Brian Polo (ORCID: https://orcid.org/0009-0002-7505-9050)
- David Sang
- Eric Ochomo (ORCID: https://orcid.org/0000-0002-4042-4970)
- Margaret Muchoki
- Bernard Abong’o (ORCID: https://orcid.org/0000-0002-5038-604X)
- Celestine Wekesa
- Patrick Mburugu (ORCID: https://orcid.org/0000-0001-7635-5236)
- Maxwell G. Machani (ORCID: https://orcid.org/0000-0002-2640-130X)
- Teresa Bange
- Edith Ramaita
- Kibor Keitany
- Ismael Abbey
- Paul Kiptoo
Institutions
- Liverpool School of Tropical Medicine (GB)
- Maseno University (KE)
- Kenyatta National Hospital (KE)
- Kenya Medical Research Institute (KE)
Publication Details
- Journal
- Malaria Journal
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1186/s12936-025-05688-w
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00